| Followers | 375 |
| Posts | 16984 |
| Boards Moderated | 4 |
| Alias Born | 03/07/2014 |
Tuesday, June 29, 2021 9:43:53 AM
QNTA: MAJOR_NEW_PARTNERSHIP_NEWS_THIS_AM "Target MEXICO" !!
MedoLife Rx is GOING AFTER MEXICO FOLKS - Biiiig market !!
SALES and REVENUE WILL DRIVE THE STOCK PRICE - ALWAYS !
https://www.globenewswire.com/news-release/2021/06/29/2254737/0/en/Medolife-Rx-Enters-Partnership-Agreement-with-Leading-International-Distributor-Brings-Products-to-Mexico.html
https://finance.yahoo.com/news/medolife-rx-enters-partnership-agreement-123000718.html
THEIR CLIENT LIST IS EXTENSIVE - they get "consumer brands" CREATED IN SPANISH aka TO A "MEXICAN" audience and "inside" stores in that country as "household names" etc !
I said it before folks - they're going for LATIN AMERICA, ASIA, EASTERN EUROPE etc.
NO need to wait on the U.S. FDA - there's a MASSIVE population and sales base to be had GLOBALLY and THAT is where the "big money" is at !!
QUOTE:
Xoles,Mexico: The exclusive partnership agreement grants Xoles the sole opportunity to market and sell Medolife’s proprietary product line throughout Mexico through its broad network with thousands of retail locations, as well as through various direct-to-consumer e-commerce channels.
Xoles has strong relationships throughout the country with the largest drugstore chains and global big box retailers.
Distribution will include Medolife’s leading product line, called Immunapen™, that includes four formulations specifically designed to promote general wellness aspects of consumers’ lives such as sleep, immunity support, anti-anxiety, and energy and focus.
This product line was created in response to the COVID-19 pandemic to address health concerns revolving around immunity, stress, anxiety and lack of energy.
The Immunapen™ product line contains a natural version of the peptides used in the Company’s lead drug candidate Escozine® that are amplified by Medolife’s proprietary polarization technology.
"
END QUOTE
https://medolife.com/
MedoLife Rx is GOING AFTER MEXICO FOLKS - Biiiig market !!
SALES and REVENUE WILL DRIVE THE STOCK PRICE - ALWAYS !
https://www.globenewswire.com/news-release/2021/06/29/2254737/0/en/Medolife-Rx-Enters-Partnership-Agreement-with-Leading-International-Distributor-Brings-Products-to-Mexico.html
https://finance.yahoo.com/news/medolife-rx-enters-partnership-agreement-123000718.html
THEIR CLIENT LIST IS EXTENSIVE - they get "consumer brands" CREATED IN SPANISH aka TO A "MEXICAN" audience and "inside" stores in that country as "household names" etc !
I said it before folks - they're going for LATIN AMERICA, ASIA, EASTERN EUROPE etc.
NO need to wait on the U.S. FDA - there's a MASSIVE population and sales base to be had GLOBALLY and THAT is where the "big money" is at !!
QUOTE:
Xoles,Mexico: The exclusive partnership agreement grants Xoles the sole opportunity to market and sell Medolife’s proprietary product line throughout Mexico through its broad network with thousands of retail locations, as well as through various direct-to-consumer e-commerce channels.
Xoles has strong relationships throughout the country with the largest drugstore chains and global big box retailers.
Distribution will include Medolife’s leading product line, called Immunapen™, that includes four formulations specifically designed to promote general wellness aspects of consumers’ lives such as sleep, immunity support, anti-anxiety, and energy and focus.
This product line was created in response to the COVID-19 pandemic to address health concerns revolving around immunity, stress, anxiety and lack of energy.
The Immunapen™ product line contains a natural version of the peptides used in the Company’s lead drug candidate Escozine® that are amplified by Medolife’s proprietary polarization technology.
"
END QUOTE
https://medolife.com/
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
